WO2016189549A1 - A novel process for the preparation of ethacrynate sodium - Google Patents

A novel process for the preparation of ethacrynate sodium Download PDF

Info

Publication number
WO2016189549A1
WO2016189549A1 PCT/IN2016/050151 IN2016050151W WO2016189549A1 WO 2016189549 A1 WO2016189549 A1 WO 2016189549A1 IN 2016050151 W IN2016050151 W IN 2016050151W WO 2016189549 A1 WO2016189549 A1 WO 2016189549A1
Authority
WO
WIPO (PCT)
Prior art keywords
sodium
sodium salt
carboxylic acid
formula
ethacrynate
Prior art date
Application number
PCT/IN2016/050151
Other languages
French (fr)
Inventor
Manik Reddy Pullagurla
Mecheril Valsan NANDA KUMAR
Varadaraju Tirumala GRUDANTI
Bharath Reddy GAJJALA
Jagadeesh Babu Rangisetty
Original Assignee
Biophore India Pharmaceuticals Pvt. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophore India Pharmaceuticals Pvt. Ltd. filed Critical Biophore India Pharmaceuticals Pvt. Ltd.
Publication of WO2016189549A1 publication Critical patent/WO2016189549A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part

Definitions

  • the invention relates to an improved process for the preparation of Ethacrynate sodium of Formula-I. More particularly, the invention relates to an improved process for the preparation of Ethacrynate sodium of Formula I in a substantially pure form with a purity level greater than 99% wherein known impurities illustrated below as Formula II, Formula III, Formula IV and Formula V are either absent in the final product or are very well controlled and under the limit of as low as below 0.1% w/w.
  • the invention also relates to highly pure crystalline form of Ethacrynate sodium and a process for the preparation thereof.
  • Ethacrynic acid structurally as represented in Formula la below and chemically known as [2,3-dichloro-4-(2-methylene-l-oxobutyl) phenoxy] acetic acid is a white or practically white, crystalline powder. It is soluble in most of the organic solvents such as alcohols but very slightly soluble in water. Ethacrynic acid is supplied as a tablet for oral use. But Ethacrynic acid sodium (Ethacrynate sodium) of Formula I is soluble in water at 25 °C to the extent of about 7 %. Ethacrynic acid sodium salts (SODIUM EDECRIN) are relatively stable at pH 7 at room temperature. Ethacrynic sodium salt is supplied as a sterile freeze dried powder and administered intravenously. Ethacrynate sodium is used in the treatment of high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure and kidney failure.
  • R. J. Yarwood, and J. H. Collett discloses preparation of crystalline form of Ethacrynate sodium by uisng freeze-dried technique. Also, they inivestiagted water content as well as storage conditions related to its stability. All the known methods for the synthesis of Ethacrynic acid sodium involve the reaction of Ethacrynic acid with NaOH or Sodium bicarbonate solution and isolating the product using freeze drying or lyophilization. Since the Active Pharmaceutical Ingredient (API) is isolating directly from the aqueous solution, it is difficult to control the sodium content as well as the inorganic materials present in the API.
  • API Active Pharmaceutical Ingredient
  • Primary object of the invention to provide a novel process for the preparation of highly pure Ethacrynate sodium of formula I.
  • Another object of the invention is to provide a novel process for preparing highly pure Ethacrynate sodium of formula I, with purity level greater than 99%.
  • Another object of the invention is to provide a highly pure crystalline form of Ethacrynic acid sodium of formula I (Ehacrynate sodium).
  • a further object of the invention is to provide novel processes for preparing highly pure crystalline Ethacrynic acid sodium of formula I (Ehacrynate sodium).
  • Yet another object of the invention is to provide substantially pure crystalline form of Ethacrynic acid sodium of formula I (Ehacrynate sodium) with known impurities represented by formula II, III, IV and formula V less than 0.1% w/w.
  • the present invention provides an improved process for the preparation of highly pure Ethacrynate sodium of formula I as shown in below reaction scheme-
  • the above process comprises the steps of:
  • step (c) filtering and washing the solid with polar protic solvent or mixture thereof; wherein the step (a) involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa); and wherein the reaction steps (a) and (b) are carried out at temperature range about 25-80 °C.
  • the invention provides an improved process for the preparation of highly pure Ethacrynate sodium of formula I comprising the steps of:
  • the present invention provides a process for preparing highly pure crystalline form of Ethacrynate sodium (Formula I) as shown in below reaction scheme-
  • the crystalline form obtained above is characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta.
  • the quantity of sodium salt of alkyl carboxylic acid in step (a) is in an amount ranging from 0.5 to 1.4 equivalents; preferably in an amount ranging from 0.8 to 1.3 equivalents.
  • the sodium ion source sodium salt of alkyl carboxylic acid in step (a) is selected from group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate) or the like; preferably the sodium salt of alkyl carboxylic acid in step (a) is sodium 2-ethyl hexanoate.
  • the solvent(s) is/are a single solvent or mixture of any two solvents selected from the group comprising lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol and n-butanol; preferably when mixture is used the solvent is mixture of isopropyl alcohol and methanol.
  • the final product Ethacrynate sodium of formula I as obtained by any of above said processes is greater than 99% pure and comprises less than 0.1% w/w of known impurities of formula II, formula III, formula IV and formula V.
  • the above said isolation step (e) comprises the steps of filtration, washing and drying or the combinations thereof.
  • the above said step (d) is performed at a temperature range of -5 to 30°C or preferably at 10 to 35°C for a period of 1-2 hrs.
  • the present invention further provides a crystalline form of Ethacrynic acid sodium of formula I, wherein said crystalline form is characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta and further characterized X-ray diffraction having the peaks as depicted in below table- 1, X-ray diffraction as depicted in figure- 1 and differential scanning chromatogram (DSC) as depicted in Figure-2.
  • Figure- 1 Illustrates a powder X-ray diffraction pattern of crystalline form of Ethacrynic acid sodium (Ethacrynate sodium, formula I).
  • Figure-2 Illustrates a differential scanning chromatogram of crystalline form of Ethacrynic acid sodium (Ethacrynate sodium, formula I).
  • the present invention discloses an improved process for the preparation of Ethacrynate sodium (Formula I) in a substantially pure form with purity level greater than 99%, wherein known impurities such as Formula II, Formula III, Formula IV and Formula V as shown below are absent in the final product or very well controlled under the limit.
  • the final product comprises less than 0.1% w/w of impurity compounds of structural formula II, III, IV and formula V.
  • Compound of formula I is used as an API in the pharmaceutical preparations/composition used in the treatment of high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure and kidney failure.
  • the present invention provides novel processes for the preparation of Ethacrynic acid sodium (Ethacrynate sodium, Formula I) in significantly high yield and substantially pure crystalline form as shown in below Scheme- 1:
  • the present process involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa) in an organic solvent or mixture of organic solvents.
  • the salt formation of Ethacrynic acid with sodium salt of alkyl ((R represent alkyl and Na represent sodium), i.e., methyl, ethyl, propyl, etc) carboxylic acid can be carried out at 25 to 80 °C and the quantity of sodium salt of alkyl carboxylic acid can be used in amount ranging from 0.5 to 1.4 equivalents.
  • Suitable sodium salt of alkyl carboxylic acid used for this reaction step may be selected from the group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt or the like.
  • Suitable organic solvent or mixture thereof may be selected from polar solvents selected from the group comprising lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, ft-propanol, n-butanol etc and mixtures thereof.
  • the sodium salt of alkyl carboxylic acid (RCOONa) used is sodium 2- ethyl hexanoate.
  • Number of equivalents of sodium salt of alkyl carboxylic acid used ranges from 0.5 to 1.4 equivalents and in one particular reaction the quantity used is from about 0.8 to 1.3 equivalents.
  • Temperature of the reaction ranges from about 40 to 80 °C and best results is obtained at temperature range of 60-80 °C.
  • the product is isolated from the reaction mixture by cooling it to a temperature range from about -5 to 30°C.
  • Ethacrynic acid sodium is slurred in polar protic solvents or mixtures thereof.
  • Ethacrynic Acid sodium obtained by the present process is 95-98% pure and is further purified from polar protic solvents selected from the group comprising alcohols like Methanol, Ethanol, Isopropyl alcohol; water; or mixtures thereof.
  • the major process impurities which are eliminated during the purification of Ethacrynic acid sodium according to the present invention are impurities of formula II, III, IV and V (as shown above), thus obtaining Ethacrynic acid sodium in substantially pure form with a purity greater than 99%.
  • the present invention provides a novel process for preparing Ethacrynic acid sodium of formula I comprising the steps of:
  • step (a) involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa).
  • the said polar protic solvents are solvents selected from the group comprising alcohols like Methanol, Ethanol, Isopropyl alcohol; water; or mixtures thereof.
  • the organic solvent used is mixture of Isopropyl alcohol and Methanol (MeOH).
  • the said sodium salt of alkyl carboxylic acid is selected from group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt or the like.
  • the said sodium salt of alkyl carboxylic acid is 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate).
  • Ethacrynic acid sodium of formula I
  • the said crystalline form of Ethacrynic acid sodium is characterized by powder X-ray diffraction pattern as presented in Figure- 1 and differential scanning chromatogram (DSC) as presented in Figure-2.
  • the crystalline form of sodium ethacrynate may be formed by slurring the solution of sodium ethacrynate polar protic solvents at a temperature in the range of 10 to 35°C for a period of 1-2 hrs.
  • the crystalline form of ethacrynic acid sodium may be isolated by the steps of filtration, washing and drying or the combinations thereof.
  • the crystalline form of ethacrynic acid sodium is obtained by slurring ethacrynic acid sodium in a mixture of 1% water in polar aprotic solvent at 25-30°C for 1- 2 hrs.
  • the isolated crystalline form of sodium ethacrynate may be dried at a temperature of less than 50°C under reduced pressure until MC (Moisture Content) reaches between 5 to 6.5.
  • the present invention provides a crystalline form of Ethacrynate sodium which may be characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta.
  • the crystalline form of said Ethcrynate sodium may be characterized by X-ray diffraction as depicted in figure- 1.
  • the said crystalline form of Ethacrynate sodium may be characterized by X-ray diffraction having the peaks as depicted in table- 1.
  • the invention provides a process for preparing crystalline form of Ethacrynate sodium (Formula I) comprising the steps of : (a) treating a solution of Ethacrynic acid (formula la) in polar solvent with a solution of sodium ion source in polar protic solvent to get Ethacrynate sodium solution at 50-55°C;
  • Another aspect the invention provides substantially pure crystalline form of ethacrynic acid sodium (Ethacrynate sodium) having impurities less than 0.1% w/w of compounds of structural formula II, III, IV and formula V.
  • the Ethacrynic acid sodium (formula I) obtained is more than 99% pure and comprises impurities less than 0.1% w/w of com ounds of structural formula II, III, IV and formula V (2-ethylhexanoic acid).
  • the sodium ethacrynate as obtained by the novel process by any of the processes as described above and above Scheme- 1 and Scheme-2 is substantially pure, more specifically greater than 99% pure; and the known impuritis such as impurity Formula II, III, IV and V are absent or very well controlled under the limit, more specifically said impurities are less than 0.1% w/w in the fiinal product.
  • sodium salt of alkyl carboxylic acids when used herein includes linear or branched alkyl groups of carboxylic acid sodium such as sodium methylcarboxylic acid, sodium ethylcarboxylic acid, sodium propylcarboxylic acid, sodium isopropyl carboxylic acids , sodium 2-ethyl hexanoate or the like.
  • 'alcoholic solvent' when used herein includes lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol, n-butanol or the like.
  • solvent when used herein includes protic solvent, or mixtures thereof.
  • API Active Pharmaceutical Ingredient

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention describes a novel process for the preparation of Ethacrynate sodium. The process involves the treatment of Ethacrynic acid with equimolar amount of sodium salt of alkyl carboxylic acid in the presence of organic solvents. The product obtained by the process is substantially pure form (purity greater than 99%) and limits known impurities below 0.1% w/w. The process also relates to a crystalline form of Ethacrynate sodium and a process for its preparation. The process is efficient and cost effective method for the commercial scale production of substantially pure stable form of Ethacrynate sodium.

Description

A NOVEL PROCESS FOR THE PREPARATION OF ETHACRYNATE SODIUM
FIELD OF THE INVENTION
The invention relates to an improved process for the preparation of Ethacrynate sodium of Formula-I. More particularly, the invention relates to an improved process for the preparation of Ethacrynate sodium of Formula I in a substantially pure form with a purity level greater than 99% wherein known impurities illustrated below as Formula II, Formula III, Formula IV and Formula V are either absent in the final product or are very well controlled and under the limit of as low as below 0.1% w/w. The invention also relates to highly pure crystalline form of Ethacrynate sodium and a process for the preparation thereof.
Figure imgf000002_0001
BACKGROUND OF THE INVENTION
Ethacrynic acid (EDECRIN), structurally as represented in Formula la below and chemically known as [2,3-dichloro-4-(2-methylene-l-oxobutyl) phenoxy] acetic acid is a white or practically white, crystalline powder. It is soluble in most of the organic solvents such as alcohols but very slightly soluble in water. Ethacrynic acid is supplied as a tablet for oral use. But Ethacrynic acid sodium (Ethacrynate sodium) of Formula I is soluble in water at 25 °C to the extent of about 7 %. Ethacrynic acid sodium salts (SODIUM EDECRIN) are relatively stable at pH 7 at room temperature. Ethacrynic sodium salt is supplied as a sterile freeze dried powder and administered intravenously. Ethacrynate sodium is used in the treatment of high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure and kidney failure.
Figure imgf000003_0001
Ethacrynate sodium Ethacrynic acid (Formula la)
In 1985, R. J. Yarwood, and J. H. Collett (i.e., Drug Development and Industrial Pharmacy,! ! -1985, 461-472) discloses preparation of crystalline form of Ethacrynate sodium by uisng freeze-dried technique. Also, they inivestiagted water content as well as storage conditions related to its stability. All the known methods for the synthesis of Ethacrynic acid sodium involve the reaction of Ethacrynic acid with NaOH or Sodium bicarbonate solution and isolating the product using freeze drying or lyophilization. Since the Active Pharmaceutical Ingredient (API) is isolating directly from the aqueous solution, it is difficult to control the sodium content as well as the inorganic materials present in the API. Another drawback in the known art is the requirement of freeze drying or lyophlization for the isolation of the API, which is not suitable for the commercial production. Therefore, there is a need to develop an efficient and cost effective method for the commercial scale production of substantially pure stable form of Ethacrynate sodium, which is free from the above mentioned problems and known impurities.
OBJECTS OF THE INVENTION
Primary object of the invention to provide a novel process for the preparation of highly pure Ethacrynate sodium of formula I.
Another object of the invention is to provide a novel process for preparing highly pure Ethacrynate sodium of formula I, with purity level greater than 99%.
Another object of the invention is to provide a highly pure crystalline form of Ethacrynic acid sodium of formula I (Ehacrynate sodium). A further object of the invention is to provide novel processes for preparing highly pure crystalline Ethacrynic acid sodium of formula I (Ehacrynate sodium).
Yet another object of the invention is to provide substantially pure crystalline form of Ethacrynic acid sodium of formula I (Ehacrynate sodium) with known impurities represented by formula II, III, IV and formula V less than 0.1% w/w.
SUMMARY OF THE INVENTION
In one aspect the present invention provides an improved process for the preparation of highly pure Ethacrynate sodium of formula I as shown in below reaction scheme-
CI O
CI
Figure imgf000004_0001
Etiiacryiiic acid Ethacrynate sodium {Formula la) (Formula I)
The above process comprises the steps of:
(a) treating a solution of Ethacrynic acid (formula la) solution in polar protic solvent with sodium salt of alkyl carboxylic acid solution in polar protic solvent;
(b) heating the solution for 1-2 hrs;
(c) filtering and washing the solid with polar protic solvent or mixture thereof; wherein the step (a) involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa); and wherein the reaction steps (a) and (b) are carried out at temperature range about 25-80 °C. In another aspect, the invention provides an improved process for the preparation of highly pure Ethacrynate sodium of formula I comprising the steps of:
(a) treating a solution of Ethacrynic acid (formula la) in polar protic solvent or mixture thereof with sodium salt of alkyl carboxylic acid solution in polar protic solvent or mixture thereof at 50-55°C; (b) heating the solution for 1-2 hrs at 75-80 °C;
(c) filtering and washing the solid with polar protic solvent or mixture thereof.
In another aspect the present invention provides a process for preparing highly pure crystalline form of Ethacrynate sodium (Formula I) as shown in below reaction scheme-
Figure imgf000005_0001
comprising the steps of:
(a) treating a solution of Ethacrynic acid (formula la) in polar solvent with a solution of sodium ion source in polar protic solvent to get Ethacrynate sodium solution at 50-55°C;
(b) heating the solution for 1-2 hrs at 70-80°C;
(c) cooling the suspension and filtering the solid at 25-30°C;
(d) washing and slurring the solid in polar protic solvents or mixtures thereof;
(e) isolating Ethacrynate sodium (formula I) and drying at below 55°C.
The crystalline form obtained above is characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta.
In any of the above process the quantity of sodium salt of alkyl carboxylic acid in step (a) is in an amount ranging from 0.5 to 1.4 equivalents; preferably in an amount ranging from 0.8 to 1.3 equivalents.
In any of the above process the sodium ion source sodium salt of alkyl carboxylic acid in step (a) is selected from group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate) or the like; preferably the sodium salt of alkyl carboxylic acid in step (a) is sodium 2-ethyl hexanoate. In any of the above process the solvent(s) is/are a single solvent or mixture of any two solvents selected from the group comprising lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol and n-butanol; preferably when mixture is used the solvent is mixture of isopropyl alcohol and methanol.
The final product Ethacrynate sodium of formula I as obtained by any of above said processes is greater than 99% pure and comprises less than 0.1% w/w of known impurities of formula II, formula III, formula IV and formula V.
Figure imgf000006_0001
The above said isolation step (e) comprises the steps of filtration, washing and drying or the combinations thereof. The above said step (d) is performed at a temperature range of -5 to 30°C or preferably at 10 to 35°C for a period of 1-2 hrs.
In another aspect the present invention further provides a crystalline form of Ethacrynic acid sodium of formula I, wherein said crystalline form is characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta and further characterized X-ray diffraction having the peaks as depicted in below table- 1, X-ray diffraction as depicted in figure- 1 and differential scanning chromatogram (DSC) as depicted in Figure-2. Table- 1
Figure imgf000007_0001
BRIEF DESCRIPTION OF THE DRAWINGS/FIGURES
Figure- 1: Illustrates a powder X-ray diffraction pattern of crystalline form of Ethacrynic acid sodium (Ethacrynate sodium, formula I).
Figure-2: Illustrates a differential scanning chromatogram of crystalline form of Ethacrynic acid sodium (Ethacrynate sodium, formula I).
DETAILED DESCRIPTION THE INVENTION
The present invention discloses an improved process for the preparation of Ethacrynate sodium (Formula I) in a substantially pure form with purity level greater than 99%, wherein known impurities such as Formula II, Formula III, Formula IV and Formula V as shown below are absent in the final product or very well controlled under the limit. The final product comprises less than 0.1% w/w of impurity compounds of structural formula II, III, IV and formula V. Compound of formula I is used as an API in the pharmaceutical preparations/composition used in the treatment of high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure and kidney failure.
Figure imgf000008_0001
Thus in one aspect, the present invention provides novel processes for the preparation of Ethacrynic acid sodium (Ethacrynate sodium, Formula I) in significantly high yield and substantially pure crystalline form as shown in below Scheme- 1:
Figure imgf000008_0002
Etiiacryaic acid Ethacrynate sodium
(Foi!iiala la) (Formula I)
Scheme- 1
The present process involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa) in an organic solvent or mixture of organic solvents. The salt formation of Ethacrynic acid with sodium salt of alkyl ((R represent alkyl and Na represent sodium), i.e., methyl, ethyl, propyl, etc) carboxylic acid can be carried out at 25 to 80 °C and the quantity of sodium salt of alkyl carboxylic acid can be used in amount ranging from 0.5 to 1.4 equivalents.
Suitable sodium salt of alkyl carboxylic acid used for this reaction step may be selected from the group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt or the like.
Suitable organic solvent or mixture thereof may be selected from polar solvents selected from the group comprising lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, ft-propanol, n-butanol etc and mixtures thereof. In one embodiment, the sodium salt of alkyl carboxylic acid (RCOONa) used is sodium 2- ethyl hexanoate. Number of equivalents of sodium salt of alkyl carboxylic acid used ranges from 0.5 to 1.4 equivalents and in one particular reaction the quantity used is from about 0.8 to 1.3 equivalents. Temperature of the reaction ranges from about 40 to 80 °C and best results is obtained at temperature range of 60-80 °C.
Finally, the product is isolated from the reaction mixture by cooling it to a temperature range from about -5 to 30°C.
In another aspect the obtained Ethacrynic acid sodium is slurred in polar protic solvents or mixtures thereof. Ethacrynic Acid sodium obtained by the present process is 95-98% pure and is further purified from polar protic solvents selected from the group comprising alcohols like Methanol, Ethanol, Isopropyl alcohol; water; or mixtures thereof.
The major process impurities which are eliminated during the purification of Ethacrynic acid sodium according to the present invention are impurities of formula II, III, IV and V (as shown above), thus obtaining Ethacrynic acid sodium in substantially pure form with a purity greater than 99%.
In one aspect the present invention provides a novel process for preparing Ethacrynic acid sodium of formula I comprising the steps of:
(a) treating a solution of Ethacrynic acid (formula la) in polar protic solvent or mixture thereof with sodium salt of alkyl carboxylic acid solution in polar protic solvent or mixture thereof at 50-55°C;
(b) heating the solution for 1-2 hrs at 75-80 °C;
(c) filtering and washing the solid with polar protic solvent or mixture thereof;
wherein the step (a) involves treatment of Ethacrynic acid (Formula la) with equimolar amount of sodium salt of alkyl carboxylic acid (RCOONa).
The said polar protic solvents are solvents selected from the group comprising alcohols like Methanol, Ethanol, Isopropyl alcohol; water; or mixtures thereof. In one embodiment the organic solvent used is mixture of Isopropyl alcohol and Methanol (MeOH).
The said sodium salt of alkyl carboxylic acid is selected from group comprising sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid or 2-ethyl hexanoic acid sodium salt or the like. Preferably in one embodiment, the said sodium salt of alkyl carboxylic acid is 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate).
In another aspect of the invention provides a crystalline form of Ethacrynic acid sodium of formula I, wherein the said crystalline form of Ethacrynic acid sodium (Ethacrynate sodium, formula I) is characterized by powder X-ray diffraction pattern as presented in Figure- 1 and differential scanning chromatogram (DSC) as presented in Figure-2.
The crystalline form of sodium ethacrynate may be formed by slurring the solution of sodium ethacrynate polar protic solvents at a temperature in the range of 10 to 35°C for a period of 1-2 hrs. The crystalline form of ethacrynic acid sodium may be isolated by the steps of filtration, washing and drying or the combinations thereof.
Optionally the crystalline form of ethacrynic acid sodium is obtained by slurring ethacrynic acid sodium in a mixture of 1% water in polar aprotic solvent at 25-30°C for 1- 2 hrs.
The isolated crystalline form of sodium ethacrynate may be dried at a temperature of less than 50°C under reduced pressure until MC (Moisture Content) reaches between 5 to 6.5.
In one embodiment the present invention provides a crystalline form of Ethacrynate sodium which may be characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta.
The crystalline form of said Ethcrynate sodium may be characterized by X-ray diffraction as depicted in figure- 1.
The said crystalline form of Ethacrynate sodium may be characterized by X-ray diffraction having the peaks as depicted in table- 1.
Table-1:
Figure imgf000011_0001
33.18 2.69 100
33.58 2.66 6
36.63 2.45 8
40.11 2.24 7
43.64 2.07 8
Thus in one embodiment the invention provides a process for preparing crystalline form of Ethacrynate sodium (Formula I) comprising the steps of : (a) treating a solution of Ethacrynic acid (formula la) in polar solvent with a solution of sodium ion source in polar protic solvent to get Ethacrynate sodium solution at 50-55°C;
(b) heating the solution for 1-2 hrs at 70-80°C;
(c) cooling the suspension and filtering the solid at 25-30°C;
(d) washing and slurring the solid in polar protic solvents or mixtures thereof;
(e) isolating Ethacrynate sodium (formula I) and drying at below 55°C.
Another aspect the invention provides substantially pure crystalline form of ethacrynic acid sodium (Ethacrynate sodium) having impurities less than 0.1% w/w of compounds of structural formula II, III, IV and formula V.
In one embodiment in any of the above said processes, the Ethacrynic acid sodium (formula I) obtained is more than 99% pure and comprises impurities less than 0.1% w/w of com ounds of structural formula II, III, IV and formula V (2-ethylhexanoic acid).
Figure imgf000012_0001
Ethacrynic acid Fromula I
Scheme-2 Moreover, the sodium ethacrynate as obtained by the novel process by any of the processes as described above and above Scheme- 1 and Scheme-2, is substantially pure, more specifically greater than 99% pure; and the known impuritis such as impurity Formula II, III, IV and V are absent or very well controlled under the limit, more specifically said impurities are less than 0.1% w/w in the fiinal product.
In order to test the advantages of the developed process over the prior art procedure, ethacrynic acid sodium is synthesized using NaOH (1.1 equiv.) and NaHC03 (l.lequiv.) as the source of sodium. It is observed that the acid impurity II is increased from 0.33 % to 3.33 % under the reaction conditions. Comparison of purities of sodium Ethacrynate synthesized using inorganic bases and 2-ethyl hexanoate is presented in Table 2.
Table-2: Comparison study of preparation of Ethacrynate sodium with different reagents
Figure imgf000013_0001
ND: Not Detected
In conclusion, the authors have disclosed a novel process for the synthesis of Ethacrynate sodium.
DEFINITIONS
The following terms shall have for the purpose of this application, including the claims appended here to, the respective meanings set forth below.
The term "sodium salt of alkyl carboxylic acids" when used herein includes linear or branched alkyl groups of carboxylic acid sodium such as sodium methylcarboxylic acid, sodium ethylcarboxylic acid, sodium propylcarboxylic acid, sodium isopropyl carboxylic acids , sodium 2-ethyl hexanoate or the like.
The term 'alcoholic solvent' when used herein includes lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol, n-butanol or the like.
The term solvent when used herein includes protic solvent, or mixtures thereof.
MC: Moisture Content
API: Active Pharmaceutical Ingredient The following examples further illustrate the present invention, but should not be construed in any way as to limit its scope.
Example- 1
Preparation of Ethacrynate Sodium of formula I
A solution of Ethacrynic acid (formula la) (30 g, 0.098 mol) in isopropyl alcohol (240 mL) was added a solution of sodium 2-ethyl hexanoate (19.7 g, 0.118 mol) in 240 ml of isopropyl alcohol at 50-55°C. The resultant solid suspension was stirred at same temperature for 2.0 hr. Then, raised the reaction mass temperature to 75-80°C and stirred for 2.0 hr. The resulting solid suspension was cooled to room temperature, filtered and washed with isopropyl alcohol (150 mL). The obtained solid was dried for 10-12 hr at below 55 °C under reduced pressure to get title compound as white solid.
Yield: (30 g, 93%)
Purity: 99.82 (by HPLC)
Example-2
Preparation of Ethacrynate Sodium of formula I
A solution of sodium 2-ethyl hexanoate (6.57 g, 0.039mol) in 80mL of isopropyl alcohol was heated to 50-55 °C. Then, added a solution of ethacrynic acid (formula la) (10 g, 0.032 mol) in isopropyl alcohol (80 mL) at same temperature. The resultant solid suspension was stirred at same temperature for 2.0 hr. Then, raised the reaction mass temperature to 75-80 °C and stirred for 2.0 hr. The resulting solids were filtered and washed with isopropyl alcohol (50 mL). The obtained solid was dried under reduced pressure for 10-12 hr at below 55 °C to get title compound as white solid.
Yield: (9.5 g, 88%) Purity: 99.79 (by HPLC)
Example-3
Preparation of Ethacrynate Sodium of formula I
A solution of ethacrynic acid (formula la) (10 g, 0.032 mol) in isopropyl alcohol :MeOH (60:20 mL) was added a solution of sodium 2-ethyl hexanoate (4.38 g, 0.026 mol) in 80 mL of isopropyl alcohol: MeOH (6:2) at 50-55 °C. The resultant solid suspension was stirred at same temperature for 2.0 hr. Then, raised the reaction mass temperature to 75-80 °C and stirred for 2.0 hr. The resulting solids were filtered, washed with isopropyl alcohol (50 mL) and dried under reduced pressure for 10-12 hr at below 55 °C to get title compound as white solid.
Yield: (9.0 g, 84%)
Purity: 99.62 (by HPLC) Example-4
Preparation of Ethacrynate Sodium of formula I
A solution of ethacrynic acid (formula la) (25 g, 0.082 mol) in isopropyl alcohol (200 mL) was added a solution of sodium 2-ethyl hexanoate (13.7 g, 0.082 mol) in 200 mL of isopropyl alcohol at 50-55 °C. The resultant solid suspension was stirred at same temperature for 2.0 hr. Then, raised the reaction mass temperature to 75-80 °C and stirred for 2.0 hr. The resulting solids were cooled to room temperature, filtered and washed with isopropyl alcohol (150 mL). The obtained solid was dried for 10-12 hr at below 55 °C under reduced pressure to get title compound as white solid.
Yield: (9.0 g, 90%)
Purity: 99.86 (by HPLC)
Example-5
Preparation of Ethacrynate Sodium of formula I
A solution of sodium 2-ethyl hexanoate (6.57 g, 0.039 mol) in 80 mL of isopropyl alcohol was heated to 50-55 °C. Then, added a solution of ethacrynic acid (formula la) (10 g, 0.032 mol) in isopropyl alcohol (80 mL) at same temperature. The resultant solid suspension was stirred at same temperature for 2.0 hr. Then, raised the reaction mass temperature to 75-80 °C and stirred for 2.0 hr. The resulting solids were cooled to 0-5°C and filtered, washed with isopropyl alcohol (50 mL). The obtained solid was dried under reduced pressure for 10-12 hr at below 55 °C to get title compound as white solid.
Yield: (9.8 g, 85%)
Purity: 99.8 (by HPLC)
Example-6
Preparation of Ethacrynate Sodium of formula I
A solution of sodium 2-ethyl hexanoate (6.02 g, 0.039 mol) in 80 mL of isopropyl alcohol was heated to 50-55 °C. Then, added a solution of ethacrynic acid (formula la) (10 g, 0.032 mol) in isopropyl alcohol (80 mL) at same temperature. The resultant solid suspension was stirred at same temperature for 15 minutes. Then, raised the reaction mass temperature to 70-75 °C and stirred for 1.0 hr. The resulting solids were cooled to 20-25°C and filtered, washed with isopropyl alcohol (50 mL). The obtained solid was dried under reduced pressure for 10-12 hr at below 55 °C to get title compound as white solid.
Yield: 80-85%
Purity: 99.9 (by HPLC)
Example-7
Process to remove unreacted Ethacrynic acid and 2-ethylhexanoic acid (formula V) impurity:
10 g of ethacrynic acid (formula la) sodium was dissolved in 100 ml of Isopropyl alcohol and stirred for 30 minutes at 25-30°C. Filtered and washed the solid with 100 ml of Isopropyl alcohol. The above obtained solid was taken in 80 ml of Isopropyl alcohol and dried under vacuum for 4-5hrs at 40-45°C until MC complies (MC limit: 5.0-6.5). If MC does not comply then the obtained solid was taken into 80 ml of 1% solution of water in Isopropyl alcohol mixture and stirred for 30 min at 25-30 °C. Filtered and washed the solid with 2X100 mL of Isopropyl alcohol. Dried the final compound under vacuum for 4- 5 hrs at 40-45 °C until MC complies.
Storage conditions: The obtained compound was stored under nitrogen atmosphere at - 20°C.
Yield: 80-85 %
Purity: 99.9(by HPLC)
MC: 5.6 % w/w

Claims

WE CLAIM:
1. A process for preparation of Ethacrynate sodium comprising the steps of:
(a) treating a solution of Ethacrynic acid in an organic solvent with sodium salt of alkyl carboxylic acid solution in an organic solvent;
(b) heating the solution of step (a) for 1-2 hrs;
(c) filtering and washing the solid with organic solvent or mixture thereof;
wherein the step (a) involves the treatment of Ethacrynic acid with equimolar amount of sodium salt of alkyl carboxylic acid, and wherein the reaction steps (a) and (b) are carried out at temperature in between 25-80 °C.
2. The process as claimed in claim 1, wherein the solvent in step (a) and step (c) is a single solvent or a mixture of the solvents selected from the group comprising of lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol and ft-butanol.
3. The process as claimed in claim 1, wherein the sodium salt of alkyl carboxylic acid in step (a) is selected from the group comprising of sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid and 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate).
4. A process for the preparation of Ethacrynate sodium comprising the steps of:
(a) treating a solution of Ethacrynic acid in polar protic solvent with sodium salt of alkyl carboxylic acid solution in polar protic solvent at 50-55°C;
(b) heating the solution of step (a) for 1-2 hrs at 75-80 °C;
(c) filtering and washing the solid with polar protic solvent or mixture thereof.
5. The process as claimed in claim 4, wherein the quantity of sodium salt of alkyl carboxylic acid in step (a) is in an amount ranging from 0.5 to 1.4 equivalents.
6. The process as claimed in claim 5, wherein the quantity of sodium salt of alkyl carboxylic acid is in an amount ranging from 0.8 to 1.3 equivalents.
7. The process as claimed in claim 4, wherein the sodium salt of alkyl carboxylic acid in step (a) is selected from group comprising of sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid and 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate).
8. The process as claimed in claim 4, wherein the solvent in step (a) and step (c) is a single solvent or a mixture of the solvents selected from the group comprising of lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol and ft-butanol.
9. The process as claimed in claims 1 or 4, wherein the Ethacrynate sodium obtained by the process has greater than 99% purity and comprises less than 0.1% w/w of known impurities of formula II, formula III, formula IV and formula V.
Figure imgf000018_0001
mpur y mpurity
10. A process for preparing highly pure crystalline form of Ethacrynate sodium comprising the steps of:
(a) treating a solution of Ethacrynic acid in polar solvent with a solution of sodium ion source in polar protic solvent to get Ethacrynate sodium solution at 50-55°C;
(b) heating the solution for 1-2 hrs at 70-80°C;
(c) cooling the suspension and filtering the solid at 25-30°C;
(d) washing and slurring the solid in polar protic solvents or mixtures thereof;
(e) isolating Ethacrynate sodium (formula I) and drying at below 55°C.
11. The process as claimed in claim 10, wherein the crystalline form of Ethacrynate sodium is characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta.
12. The process as claimed in claim 10, wherein the sodium ion source in step (a) is sodium salt of alkyl carboxylic acid selected from group comprising of sodium salt of methyl carboxylic acid, sodium salt of ethyl carboxylic acid, sodium salt of propyl carboxylic acid and 2-ethyl hexanoic acid sodium salt (sodium 2-ethyl hexanoate).
13. The process as claimed in claim 10, wherein the solvent in step (a) and step (d) is a single solvent or mixture of any two solvents selected from the group comprising lower alkyl alcohols such as ethanol, methanol, isopropyl alcohol, n-propanol and ft-butanol.
14. The process as claimed in claim 10, wherein the quantity of ion source sodium salt of alkyl carboxylic acid in step (a) is in an amount ranging from 0.5 to 1.4 equivalents.
15. The process as claimed in claim 10, wherein the step (d) is performed at a temperature range of -5 to 30°C for a period of 1-2 hrs.
16. The process as claimed in claim 10, wherein the crystalline form of Ethacrynate sodium obtained by the process has greater than 99% purity and comprises less than 0.1% w/w of known impurities of formula II, formula III, formula IV and formula V.
Figure imgf000019_0001
Figure imgf000020_0001
17. The highly pure crystalline form of Ethacrynate sodium characterized by X-ray diffraction pattern having peaks at 3.3, 6.5 and 33.2 +0.2 degrees two theta obtained by the process as claimed in claim 10, wherein said crystalline form has greater than 99% purity and comprises less than 0.1% w/w of known impurities of formula II, formula III, formula IV and formula V.
Figure imgf000020_0002
PCT/IN2016/050151 2015-05-22 2016-05-21 A novel process for the preparation of ethacrynate sodium WO2016189549A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2573CH2015 2015-05-22
IN2573/CHE/2015 2015-05-22

Publications (1)

Publication Number Publication Date
WO2016189549A1 true WO2016189549A1 (en) 2016-12-01

Family

ID=57392200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2016/050151 WO2016189549A1 (en) 2015-05-22 2016-05-21 A novel process for the preparation of ethacrynate sodium

Country Status (1)

Country Link
WO (1) WO2016189549A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10259770B2 (en) * 2016-10-22 2019-04-16 Strides Shasun Limited Process for the preparation of ethacrynic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
US3450750A (en) * 1966-07-27 1969-06-17 Merck & Co Inc (4-(2-(alkoxymethyl)alkanoyl)phenoxy)acetic acids and derivatives thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
US3450750A (en) * 1966-07-27 1969-06-17 Merck & Co Inc (4-(2-(alkoxymethyl)alkanoyl)phenoxy)acetic acids and derivatives thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE INFLUENCE OF STORAGE ON THE CRYSTALLINE STRUCTURE OF FREEZE DRIED SODIUM ETHACRYNATE: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY: 1985;, vol. 11, no. 2-3, 20 October 2008 (2008-10-20), pages 461 - 472 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10259770B2 (en) * 2016-10-22 2019-04-16 Strides Shasun Limited Process for the preparation of ethacrynic acid

Similar Documents

Publication Publication Date Title
JP2019052152A (en) Salts of treprostinil
RU2550202C2 (en) Method of synthesising ergothioneine and its analogues
KR20080091757A (en) Purification processes of echinocandin-type compounds
US8664398B2 (en) Moxifloxacin hydrochloride compounds and intermediates and methods for making same
US11225565B2 (en) Purification of sugammadex
EP3433232A1 (en) Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
JP6250629B2 (en) Crystals of high-purity cyclopeptide substances and methods for producing and using them
BG100639A (en) New crystalline form of anhydrous salt of 7-(c1,5,6!-6-amino-3-azabicycloc3.1.0!hex-3-yl)-6-fluoro-1-(2,4-di fluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthiridin-3-carboxylic acid and methane-sulphonic acid
EP3037431A1 (en) Vancomycin derivative, and preparation method and application thereof
KR20080109088A (en) Rosuvastatin zinc salt
CN111393399B (en) Prodrugs of mycophenolic acid and method for preparing same
WO2016189549A1 (en) A novel process for the preparation of ethacrynate sodium
WO2020182228A1 (en) Method of refining sodium taurocholate
WO2015087343A2 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
RU2548153C2 (en) Method for synthesis of 2-thiohistidine and analogues thereof
US20050245578A1 (en) Polymorphs of pantoprazole sodium salt and process for the preparation thereof
KR20180105450A (en) A Method of preparing Fimarsartan choline salt and hydrate thereof
EA029788B1 (en) Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine
WO2021110929A1 (en) Crystalline forms of sodium salt of bempedoic acid
WO2020217190A1 (en) Process for the purification of roxadustat
CN112079902A (en) Vancomycin derivative, intermediate, preparation method, composition and application thereof
CN106905408B (en) 1-carbonyl tanshinone IIA derivative and preparation thereof
US20100010230A1 (en) Method for the purification of lansoprazole
CA3074247A1 (en) Process for the preparation of ixazomib citrate
JPS6228154B2 (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16799489

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16799489

Country of ref document: EP

Kind code of ref document: A1